- NEWS FEATURE
Migraine is more than a headache — a radical rethink offers hope to one billion people
Illustration: Aleksandra Czudżak
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 638, 600-602 (2025)
doi: https://doi.org/10.1038/d41586-025-00456-x
References
May, A. et al. Lancet 352, 275–278 (1998).
Edvinsson, L., Haanes, K. A., Warfvinge, K. & Krause, D. N. Nature Rev. Neurol. 14, 338–350 (2018).
Schoenen, J. et al. Rev. Neurol. 176, 788–803 (2020).
May, A. & Burnstein, R. Cephalagia 39, 1710–1719 (2019).
Stankewitz, A. et al. Neuorimage Clin. 16, 102784 (2021).
Rasmussen, R. H. et al. Environ. Health Perspect. 131, 117003 (2023).
Chiang, C.-C. et al. Headache 64, 1094–1108 (2024).
Vincent, M. et al. Front Neurol. 13, 1032103 (2022).
Bie, B. et al. Sci. Rep. 14, 28673 (2024).
What causes migraines? Study of ‘brain blackout’ offers clues
Chronic pain can be treated — so why are millions still suffering?
US drug agency approves potent painkiller — the first non-opioid in decades
A new generation of headache drugs